Estrella Immunopharma, Inc.ESLANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+102.7%
5Y CAGR+77.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+102.7%/yr
Annual compound
5Y CAGR
+77.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
17.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.06M | +47.7% |
| 2024 | $8.85M | +21.0% |
| 2023 | $7.31M | +365.8% |
| 2022 | $1.57M | -6.9% |
| 2021 | $1.69M | +129.7% |
| 2020 | $733693.00 | - |